Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) ...

Colon cancer symptoms in women include diarrhea, constipation, unintended weight loss, and bloody stools. While these are the same for anyone with colon cancer, symptoms in women may be ...

Colon cancer symptoms in women include diarrhea, constipation, unintended weight loss, and bloody stools. While these are the same for anyone with colon cancer, symptoms in women may be misattributed ...

If there’s one person who helped shake the stigma of bowel cancer in the young, it was the late Dame Deborah James. The ...

Fiber digestion produces short-chain fatty acids like propionate and butyrate, which directly alter gene expression with anti ...

Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the ...

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...

This trial assessed patients with untreated metastatic colorectal cancer with microsatellite instability-high (MSI-High) or mismatch repair deficient genetic mutations (dMMR).

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...